
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Pycnogenol is a standardized extract from French maritime pine bark containing proanthocyanidins that support cardiovascular and skin health. It works primarily by scavenging free radicals and enhancing nitric oxide production in blood vessels.

Reported Benefits (Provisional)
Origin & History

Pycnogenol is an extract from the bark of the French maritime pine tree, Pinus pinaster, primarily grown in the southwest coast of France.
Research Narrative (Provisional)
Numerous studies, including randomized controlled trials, have demonstrated Pycnogenol's effectiveness in improving vascular health and reducing inflammation.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Pycnogenol is a standardized extract from the bark of French Maritime Pine (Pinus pinaster), not consumed as a macronutrient source but valued for its dense concentration of bioactive polyphenolic compounds. Key constituents include: Procyanidins (oligomeric proanthocyanidins/OPCs, comprising 65–75% of the extract), which are polymers of catechin and epicatechin units (primarily dimers through heptamers); Catechin (~2–4% free form) and Epicatechin (~1–2%), both flavan-3-ol monomers with direct antioxidant activity; Taxifolin (dihydroquercetin, ~2–5%), a potent flavonoid with anti-inflammatory properties; Phenolic acids including caffeic acid (~1–3%), ferulic acid (~0.5–1.5%), and protocatechuic acid (~0.5–1%); and Gallic acid (~trace–1%). The extract contains negligible macronutrients (no significant protein, fat, carbohydrate, or fiber) at typical supplemental doses of 50–300 mg/day. No appreciable vitamins or minerals are present in meaningful amounts. Bioavailability notes: The smaller molecular weight compounds (catechin, taxifolin, phenolic acids) are readily absorbed in the small intestine with moderate oral bioavailability. Larger procyanidin oligomers (trimers and above) have limited direct absorption but undergo extensive colonic microbial metabolism, yielding bioactive metabolites such as δ-(3,4-dihydroxyphenyl)-γ-valerolactone (M1) and δ-(3-methoxy-4-hydroxyphenyl)-γ-valerolactone (M2), which are detectable in plasma within 2–6 hours and contribute significantly to systemic bioactivity. Peak plasma concentrations of metabolites reach approximately 50–150 ng/mL after a standard 200 mg dose. The antioxidant capacity (ORAC value) of the extract is exceptionally high at approximately 3,500–4,000 µmol TE/g, roughly 20× that of vitamin C on a weight basis.
Reported Mechanism (Provisional)
Pycnogenol's proanthocyanidins inhibit angiotensin-converting enzyme (ACE) and boost endothelial nitric oxide synthase activity, improving vasodilation. The oligomeric proanthocyanidins also bind to collagen and elastin fibers, protecting them from enzymatic degradation. Additionally, it modulates NF-κB inflammatory pathways and enhances antioxidant enzyme systems including superoxide dismutase.
Clinical Narrative (Provisional)
Multiple randomized controlled trials with 50-200 participants demonstrate pycnogenol's cardiovascular benefits, with studies showing 7-10% reductions in systolic blood pressure at 100-200mg daily. Skin health studies involving 60-112 women found 8% improvements in skin hydration and elasticity after 6-12 weeks of supplementation. A meta-analysis of 13 studies confirmed significant improvements in endothelial function markers. However, most studies are relatively small and short-term, requiring larger long-term trials for definitive conclusions.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







